Skip to main content
. 2020 Dec 1;71(Suppl 3):S319–S335. doi: 10.1093/cid/ciaa1336

Table 1.

Patient and Caregiver Cost of Illness Due to Enteric Fever, Sample Characteristics, Karachi, Pakistan, September 2016–December 2018

Characteristic n %
Respondents
Patients responding to enrollment cost questionnaire 1029 100.0
Patients responding to 6-week follow-up cost questionnaire 746 72.5
Patients who died of enteric fever 1 0.1
Blood culture result
Salmonella Typhi positive 807 78.4
Salmonella Paratyphi positive 95 9.2
Not positive for either Salmonella Typhi or Paratyphi (surgical cases) 127 12.3
Drug resistance of Salmonella Typhi or Salmonella Paratyphi positive cases, n = 902
Multidrug-resistantaSalmonella Typhi or Salmonella Paratyphi positive 170 18.8
Extensively drug-resistantbSalmonella Typhi positive 401 44.5
No drug–resistant Salmonella Typhi or Salmonella Paratyphi positive 331 36.7
Age, years
<2 107 10.4
2–4 203 19.7
5–17 450 43.7
18+ 269 26.1
Sex
Male 624 60.6
Female 405 39.4
Household with mobile phone
Yes 972 94.5
No 30 2.9
Did not respond 27 2.6
Households with electricity
Yes 984 95.6
No 16 1.6
Did not respond 29 2.8
Households with car/motorcycle
Yes 676 65.7
No 326 31.7
Did not respond 27 2.6
Household roof material
Cement 982 95.4
Metal sheets, mats, ceramic, shingles 27 2.6
Natural materials 20 1.9
Households with sanitation
No toilet 7 0.7
Household flush to sewer system, septic tank,  somewhere else 983 95.5
Household pit latrine, bucket or hanging toilet,  communal toilet, other 12 1.2
Did not respond 27 2.6
Drinking water treated at home
Boil 202 19.6
Chlorine liquid, powder, or tablets 15 1.5
Other 5 0.5
Do not treat water 616 59.9
Did not respond 191 18.6

aPatients with blood culture–confirmed Salmonella Typhi or S. Paratyphi resistant to ampicillin, chloramphenicol, and cotrimoxazole. It excludes extensively drug-resistant S. Typhi cases.

bPatients with blood culture–confirmed S. Typhi resistant to ampicillin, chloramphenicol, cotrimoxazole, or ceftriaxone, and resistant to or with reduced susceptibility to fluoroquinolones (ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin, or ofloxacin). S. Paratyphi excluded because there was no extensively drug-resistant case in the sample.